These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26662423)

  • 1. Establishment of a neuroblastoma mouse model by subcutaneous xenograft transplantation and its use to study metastatic neuroblastoma.
    Gao Q; Chen CF; Dong Q; Hou L; Chen X; Zhi YL; Li X; Lu HT; Zhang HY
    Genet Mol Res; 2015 Dec; 14(4):16297-307. PubMed ID: 26662423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Establishment of subcutaneously transplanted and metastatic neuroblastoma models in nude mice].
    Lu HT; Dong Q; Gao Q; Hao XW; Song H; Zhao N
    Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):258-61. PubMed ID: 20510074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Description of a new xenograft model of metastatic neuroblastoma using NOD/SCID/Il2rg null (NSG) mice.
    Sartelet H; Durrieu L; Fontaine F; Nyalendo C; Haddad E
    In Vivo; 2012; 26(1):19-29. PubMed ID: 22210712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo echographic evidence of tumoral vascularization and microenvironment interactions in metastatic orthotopic human neuroblastoma xenografts.
    Joseph JM; Gross N; Lassau N; Rouffiac V; Opolon P; Laudani L; Auderset K; Geay JF; Mühlethaler-Mottet A; Vassal G
    Int J Cancer; 2005 Mar; 113(6):881-90. PubMed ID: 15514941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-expression-based analysis of local and metastatic neuroblastoma variants reveals a set of genes associated with tumor progression in neuroblastoma patients.
    Nevo I; Oberthuer A; Botzer E; Sagi-Assif O; Maman S; Pasmanik-Chor M; Kariv N; Fischer M; Yron I; Witz IP
    Int J Cancer; 2010 Apr; 126(7):1570-81. PubMed ID: 19739072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse.
    Ferrandis E; Da Silva J; Riou G; Bénard I
    Cancer Res; 1994 Apr; 54(8):2256-61. PubMed ID: 8174136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel metastatic animal model reflecting the clinical appearance of human neuroblastoma: growth arrest of orthotopic tumors by natural, cytotoxic human immunoglobulin M antibodies.
    Engler S; Thiel C; Förster K; David K; Bredehorst R; Juhl H
    Cancer Res; 2001 Apr; 61(7):2968-73. PubMed ID: 11306475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and characterization of new orthotopic and metastatic neuroblastoma models.
    Daudigeos-Dubus E; LE Dret L; Rouffiac V; Bawa O; Leguerney I; Opolon P; Vassal G; Geoerger B
    In Vivo; 2014; 28(4):425-34. PubMed ID: 24982206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
    Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
    Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Pilot Study on the Utility of Serum Metabolomics in Neuroblastoma Patients and Xenograft Models.
    Beaudry P; Campbell M; Dang NH; Wen J; Blote K; Weljie AM
    Pediatr Blood Cancer; 2016 Feb; 63(2):214-20. PubMed ID: 26481088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of RECK and MMPs in Hepatoblastoma and Neuroblastoma and Comparative Analysis on the Tumor Metastasis.
    Xu M; Wang HF; Zhang HZ
    Asian Pac J Cancer Prev; 2015; 16(9):4007-11. PubMed ID: 25987077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum-circulating miRNAs predict neuroblastoma progression in mouse model of high-risk metastatic disease.
    Ramraj SK; Aravindan S; Somasundaram DB; Herman TS; Natarajan M; Aravindan N
    Oncotarget; 2016 Apr; 7(14):18605-19. PubMed ID: 26921195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF expression correlates with neuronal differentiation and predicts a favorable prognosis in patients with neuroblastoma.
    Weng WC; Lin KH; Wu PY; Ho YH; Liu YL; Wang BJ; Chen CC; Lin YC; Liao YF; Lee WT; Hsu WM; Lee H
    Sci Rep; 2017 Sep; 7(1):11212. PubMed ID: 28894229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
    Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
    J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CFC1 is a cancer stemness-regulating factor in neuroblastoma.
    Chikaraishi K; Takenobu H; Sugino RP; Mukae K; Akter J; Haruta M; Kurosumi M; Endo TA; Koseki H; Shimojo N; Ohira M; Kamijo T
    Oncotarget; 2017 Jul; 8(28):45046-45059. PubMed ID: 28620148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a continuous cell line (MHH-NB-11) derived from advanced neuroblastoma.
    Pietsch T; Göttert E; Meese E; Blin N; Feickert HJ; Riehm H; Kovacs G
    Anticancer Res; 1988; 8(6):1329-33. PubMed ID: 3218965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and characterization of novel local and metastatic human neuroblastoma variants.
    Nevo I; Sagi-Assif O; Edry Botzer L; Amar D; Maman S; Kariv N; Leider-Trejo LE; Savelyeva L; Schwab M; Yron I; Witz IP
    Neoplasia; 2008 Aug; 10(8):816-27. PubMed ID: 18683320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage.
    Hoehner JC; Gestblom C; Hedborg F; Sandstedt B; Olsen L; Påhlman S
    Lab Invest; 1996 Nov; 75(5):659-75. PubMed ID: 8941212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD44 is associated with a metastatic pattern of human neuroblastoma cells in a SCID mouse xenograft model.
    Valentiner U; Valentiner FU; Schumacher U
    Tumour Biol; 2008; 29(3):152-60. PubMed ID: 18612220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of bone morphogenetic protein receptor 2 promotes the development of neuroblastoma.
    Cui X; Yang Y; Jia D; Jing Y; Zhang S; Zheng S; Cui L; Dong R; Dong K
    Biochem Biophys Res Commun; 2017 Jan; 483(1):609-616. PubMed ID: 27998774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.